Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Affect Disord. 2013 Aug 16;151(2):10.1016/j.jad.2013.07.036. doi: 10.1016/j.jad.2013.07.036

Table 2.

Substance use characteristics of the study sample at baseline assessment (N = 296)

Variable Mean (SD) or n (%)

A. METH−/HIV−(n = 73) B. METH−/HIV+ (n= 90) C. METH+/HIV−(n = 59) D. METH+/HIV+ (n = 74) Significant Differencesb
Current METH 0 (0%) 0 (0%) 3 (5%) 17 (23%) A,B,C<D
Dependence
Lifetime
Substance
Dependence
 METH 0 (0%) 0 (0%) 59 (100%) 74 (100%) A,B<C,D
 Alcohol 5 (7%) 7 (8%) 25 (42%) 17 (23%) A,B<D<C
 Cannabis 3 (4%) 4 (4%) 13 (22%) 15 (20%) A,B<C,D
METH Use Characteristics a
 Age of First Use 24 (9) 29 (10) 22 (7) 24 (7) B>C,D
 Cumulative Duration of Use (days) 54 (62) 131 (238) 4413 (2424) 2632 (2382) A,B<D<C
 Cumulative Quantity of Use (grams) 5 (6) 22 (63) 4451 (3676) 2525 (3673) A,B<D<C
 Recency of Use (days) 2552 (2504) 3593 (3037) 121 (91) 142 (168) A,B>C,D
Alcohol Use Characteristics a
 Age of First Use 16 (4) 17 (4) 14 (4) 14 (4) A,B>C,D
 Cumulative Duration of Use (days) 832 (936) 1596 (1620) 2933 (2586) 1950 (1854) A<B,D<C
 Cumulative Quantity of Use (grams) 3277 (6769) 7720 (15949) 22890 (23742) 15649 (23993) A<B<C,D
 Recency of Use (days) 610 (1351) 545 (1517) 627 (1470) 380 (842)
Cannabis Use Characteristics a
 Age of First Use 18 (4) 19 (5) 15 (3) 16 (5) A>C; B>C,D
 Cumulative Duration of Use (days) 594 (1334) 758 (1397) 3322 (3306) 3182 (3463) A,B<C,D
 Cumulative Quantity of Use (grams) 196 (412) 345 (828) 2196 (3535) 3741 (14531)
 Recency of Use (days) 2810 (3622) 2676 (3260) 1433 (2393) 1114 (2515) A,B>C,D

Note: METH = Methamphetamine; HIV = Human Immunodeficiency Virus

a

Statistics are based on observed data

b

Pairwise group comparisons were performed with Benjamini-Hochberg correction with a significance alpha level of .05. Group labels: A = METH−/HIV−, B = METH−/HIV+, C = METH+/HIV−, D = METH+/HIV+.